Position in ELUT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$117,710
+$10,952 QoQ
Shares Held
112,105
-27.2% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ELUT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $1,870,037,695 across 83 Medical Devices names. ELUT ranks #71 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
4,217,314 | $264,636,453 | |
| 2 | ABT |
Abbott Laboratories
|
1,915,846 | $196,699,908 | |
| 3 | GMED |
Globus Medical Inc
|
1,966,114 | $169,400,381 | |
| 4 | GKOS |
GLAUKOS Corp
|
1,446,926 | $155,776,052 | |
| 5 | DXCM |
Dexcom Inc
|
2,091,872 | $131,369,561 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,378,665 | $124,658,889 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
1,293,268 | $92,054,816 | |
| 8 | MDT |
Medtronic plc
|
982,741 | $85,154,507 |
All Filings in ELUT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $117,710 | 112,105 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $106,758 | 154,053 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,377 | 56,604 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $83,891 | 22,431 | Shares | Defined | 2025-02-14 | |
| 2020-12-31 | $1,543,774 | 113,263 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||